Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial

Liver Transplantation

Volumn 6, Issue 3, 2000, Pages 376-379

  Patel, Robin ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FLUCONAZOLE; PLACEBO;

ADULT; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GRAFT FAILURE; HUMAN; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MYCOSIS; NOTE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0034125595     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1527-6465(05)80022-X     Document Type: Article

References (20)

1. Schroter S.P. Hoelscher M. Putnam C.W. Porter K.A. Starzl T.E. Fungus infections after liver transplantation Ann Surg 186 1977 115 122
2. Wajsztzuk D.P. Dummer J.S. Ho M. Van Thiel D.H. Starzl T.E. Iwatsuki S. Fungal infections in liver transplant recipients Transplantation 40 1985 347 353
3. Colonna J.O. II Winston D.J. Brill J.E. Goldstein L.I. Hoff M.P. Hiatt J.R. Infectious complications in liver transplantation Arch Surg 123 1988 360 364
4. Tollemar J. Ericzon E.B. Barkholt L. Andersson J. Ringden O. Groth C.G. Risk factors for deep Candida infections in liver transplant recipients Transplant Proc 22 1990 1826 1827
5. Castaldo P. Stratta R.J. Wood R.P. Markin R.S. Patil K.D. Schaefer M.S. Fungal disease in liver transplant recipients: A multivariate analysis of risk factors Transplant Proc 23 1991 1517 1519
6. Tollemar J. Ericzon B.G. Holmberg K. Andersson J. The incidence and diagnosis of invasive fungal infections in liver transplant recipients Transplant Proc 22 1990 242 244
7. Kusne S. Dummer J.S. Singh N. Iwatsuki S. Makowka L. Esquivel C. Infections after liver transplantation: An analysis of 101 consecutive cases Medicine 67 1988 132 143
8. Castaldo P. Stratte R.J. Wood P. Markin R.S. Patil K.D. Schaefer M.D. Clinical spectrum of fungal infections after orthotopic liver transplantation Arch Surg 126 1991 149 156
9. Singh N. Gayowski T. Wagener M.M. Doyle H. Marino I.R. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent Clin Infect Dis 24 1997 179 184
10. Paya C.V. Hermans P.E. Washington J.A. II Smith T.F. Anhalt J.P. Wiesner R.H. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations Mayo Clin Proc 64 1989 555 564
11. Collins L.A. Samore M.H. Roberts M.S. Luzzati R. Jenkins R.L. Lewis W.D. Karchmer A.W. Risk factors for invasive fungal infections complicating orthotopic liver transplantation J Infect Dis 170 1994 644 652
12. Hadley S. Samore M.H. Lewis W.D. Jankins R.L. Karchmer A.W. Hammer S.M. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 asprimary immunosuppression Transplantation 59 1995 851 859
13. Winston D.J. Pakrasi A. Busuttil R.W. Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial Ann Intern Med 131 1999 729 737
14. Ruskin J.D. Wood R.P. Bailey M.R. Whitmore C.K. Shaw B.W. Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients Oral Surg Oral Med Oral Pathol 74 1992 567 571
15. Tollemar J. Hockerstedt K. Ericzon B.-G. Jalanko H. Ringden O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients Transplantation 59 1995 45 50
16. Braun F. Ruchel R. Lorf T. Canelo R. Muller A. Sartler B. Ringe B. Is liposomal amphotericin B (Ambisome) an effective prophylaxis of mycotic infections after liver transplantation? Transplant Proc 30 1998 1481 1483
17. Furtun J. Lopez-San Roman A. Velasco J.J. Sanchez-Sousa A. de Vicente E. Nuno J. Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis Eur J Clin Microbiol Infect Dis 16 1997 314 318
18. Lumbreras C. Cuervas-Mons V. Jara R. del Palacio A. Turrion V.S. Barrios C. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation J Infect Dis 174 1996 583 588
19. Patel R. Portela D. Badley A.D. Harmsen W.S. Larson-Keller J.J. Ilstrup D.M. Risk factors of invasive Candida and non- Candida fungal infections after liver transplantation Transplantation 62 1996 926 934
20. Nieto-Rodriguez J.A. Kusne S. Manez R. Irish W. Linden R. Magnone M. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients Ann Surg 223 1996 70 76